Autologous tumor-infiltrating lymphocytes (HS-IT101) with low-dose lymphodepletion and IL-2 infusion for the treatment of advanced solid tumors: A phase I clinical trial. This is an ASCO Meeting ...

Bullish price targets for Bitcion in 2030 range from $500,000 to over $1 million. If Bitcoin grows that much, a $1 investment today could be worth $5.75 or more in a few years. Although you won't get ...

Disney is taking a $1 billion equity stake in OpenAI, while also striking a deal that would allow its famous characters be used on Sora, the AI company’s video generation platform. Disney’s investment ...

Voyager 1, NASA’s deep-space probe, could soon become the first spacecraft to reach a historic milestone. In November 2026, the probe will be one light-day from Earth. Launched in 1977, Voyager 1 is ...

There’s nothing more exciting in Formula 1 than a championship-deciding final race. Think of it as a Game 7 of the NBA Finals that hinges on the final moment of the fourth quarter or a Super Bowl that ...

After attending the ASN 2025 Kidney Week, Dr Sumeska Thavarajah reflects on the exciting developments in nephrology, particularly the emergence of new drugs entering advanced clinical trials. The ...

Advances in glomerular diseases (GDs), as presented at the American Society of Nephrology (ASN) 2025 annual meeting, include updated results on pegcetacoplan, emerging targeted therapies, and data ...

A potential cure for type 1 diabetes has been identified by scientists in a new mouse study. In an animal study, researchers at Stanford School of Medicine discovered that resetting the immune system ...

Breakthroughs, discoveries, and DIY tips sent six days a week. Terms of Service and Privacy Policy. Voyager 1 is one of humanity’s most poignant and remarkable ...

Saudi Crown Prince Mohammed bin Salman committed his country to increasing his planned investment into the U.S. economy to nearly $1 trillion over the next year on Tuesday. MBS made the announcement ...

Data from the Phase III FINE-ONE trial, which investigated the safety and efficacy of finerenone versus placebo in adults with type 1 diabetes (T1D) and chronic kidney disease (CKD), will be featured ...